Stephen K. Tyring

25.4k total citations · 7 hit papers
407 papers, 16.8k citations indexed

About

Stephen K. Tyring is a scholar working on Epidemiology, Dermatology and Immunology. According to data from OpenAlex, Stephen K. Tyring has authored 407 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 179 papers in Epidemiology, 112 papers in Dermatology and 92 papers in Immunology. Recurrent topics in Stephen K. Tyring's work include Herpesvirus Infections and Treatments (79 papers), Dermatology and Skin Diseases (63 papers) and Psoriasis: Treatment and Pathogenesis (56 papers). Stephen K. Tyring is often cited by papers focused on Herpesvirus Infections and Treatments (79 papers), Dermatology and Skin Diseases (63 papers) and Psoriasis: Treatment and Pathogenesis (56 papers). Stephen K. Tyring collaborates with scholars based in United States, Canada and Germany. Stephen K. Tyring's co-authors include Kim Papp, Peter L. Rady, István Arany, Richard G. Langley, Craig L. Leonardi, Mark Lebwohl, Kristian Reich, C.E.M. Griffiths, Ralph Zitnik and Reuben Matalon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stephen K. Tyring

391 papers receiving 16.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

2014 1.5k citations Richard G. Langley, Mark Lebwohl et al. profile →
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

2005 852 citations Stephen K. Tyring, Alice B. Gottlieb et al. profile →
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

2007 695 citations Stephen K. Tyring, Kenneth B. Gordon et al. Journal of the American Academy of Dermatology profile →
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

2002 583 citations Stephen K. Tyring et al. profile →
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

2005 557 citations Kim Papp, Stephen K. Tyring et al. British Journal of Dermatology profile →
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

2017 413 citations Kristian Reich, Kim Papp et al. profile →
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

2017 392 citations Kim Papp, Andrew Blauvelt et al. profile →

Peers

Countries citing papers authored by Stephen K. Tyring

Since Specialization

Citations

This map shows the geographic impact of Stephen K. Tyring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen K. Tyring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen K. Tyring more than expected).

Fields of papers citing papers by Stephen K. Tyring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen K. Tyring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen K. Tyring. The network helps show where Stephen K. Tyring may publish in the future.

Co-authorship network of co-authors of Stephen K. Tyring

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen K. Tyring. A scholar is included among the top collaborators of Stephen K. Tyring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen K. Tyring. Stephen K. Tyring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resolution of metastatic cutaneous Crohn's disease with upadacitinib monotherapy 2024 ·JAAD Case Reports ·(unknown), (unknown), Anisha B. Patel, Stephen K. Tyring	0
2	50251 Efficacy of Risankizumab Versus Apremilast Among Patients with Scalp or Nail Psoriasis from the Phase 4 IMMpulse Study 2024 ·Journal of the American Academy of Dermatology ·Linda Stein Gold, Stephen K. Tyring, Hwanhee Hong, Lev Pavlovsky, Andreas Pinter, Adam Reich, Tianshuang Wu, (unknown), Sven Richter, Kim Papp	0
3	Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study 2023 ·Journal of Dermatological Science ·Andrew Blauvelt, David M. Pariser, Stephen K. Tyring, Jerry Bagel, Andrew Alexis, Jennifer Soung, April W. Armstrong, Elisa Muscianisi, Farid Kianifard, Jennifer Steadman, (unknown), Sandra Garcet, James G. Krueger	11
4	Buffalopox: An emerging cutaneous disease in humans 2023 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), (unknown), (unknown), (unknown), Stephen K. Tyring	1
5	Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic 2020 ·Journal of NeuroVirology ·Andrew N. Bubak, Cheryl L. Beseler, Christina N. Como, Stephen K. Tyring, Christopher T. Haley, (unknown), James E. Hassell, Randall J. Cohrs, Huntington Potter, Maria A. Nagel	11
6	The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study 2019 ·British Journal of Dermatology ·Robert Bissonnette, Catherine Maari, Seth Forman, Neal Bhatia, (unknown), Joseph F. Fowler, Stephen K. Tyring, David M. Pariser, Howard Sofen, Sunil Dhawan, (unknown), David J. Zammit, Helen Usansky, L. Denis, Niranjan Rao, Teresa Song, Ana B. Pavel, Emma Guttman‐Yassky	101
7	The efficacy of omalizumab in Cutaneous Mastocytosis: A case series 2019 ·Dermatologic Therapy ·(unknown), Daniel J. Lewis, Ramya Vangipuram, (unknown), Uyen Ngoc Mui, Christopher T. Haley, Sergej Konoplev, Stephen K. Tyring	8
8	A novel approach to the classification of epidermodysplasia verruciformis 2018 ·International Journal of Dermatology ·Simo Huang, Julie H. Wu, Daniel J. Lewis, Peter L. Rady, Stephen K. Tyring	29
9	Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials 2018 ·British Journal of Dermatology ·Andrew Blauvelt, Kristian Reich, Kim Papp, Alexa B. Kimball, Melinda Gooderham, Stephen K. Tyring, Rodney Sinclair, Diamant Thaçi, Q. Li, N. Cichanowitz, (unknown), Carmen La Rosa	60
10	Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials 2018 ·British Journal of Dermatology ·Richard G. Langley, April W. Armstrong, Mark Lebwohl, Andrew Blauvelt, Sylvia Hsu, Stephen K. Tyring, S. Rastogi, Rajamohanan K Pillai, Robert J. Israel	23
11	EFFECT OF TILDRAKIZUMAB ON PERSONAL RELATIONSHIPS IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS 2018 ·Kim Papp, Alexa B. Kimball, Andrew Blauvelt, Kristian Reich, Melinda Gooderham, Stephen K. Tyring, Rodney Sinclair, Diamant Thaçi, Yang Zhao, N. Cichanowitz, Qing Li, Carmen La Rosa	1
12	FV‐100 versus valacyclovir for the prevention of post‐herpetic neuralgia and the treatment of acute herpes zoster‐associated pain: A randomized‐controlled trial 2016 ·Journal of Medical Virology ·Stephen K. Tyring, Patricia Lee, (unknown), Joel C. Silverfield, Angela Moore, (unknown), (unknown)	14
13	Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy 2015 ·Clinical Cancer Research ·Daniel N. Cohen, (unknown), Aaron C. Shaver, Liping Du, Harrison P. Nguyen, Qin He, Douglas B. Johnson, (unknown), Brent R. Moody, James L. Prescott, Pranil Chandra, Alan S. Boyd, Jeffrey P. Zwerner, (unknown), Stephen K. Tyring, Peter L. Rady, James D. Chappell, Yu Shyr, Jeffrey R. Infante, Jeffrey A. Sosman	23
14	Current and emerging drugs for acute bacterial skin and skin structure infections: an update 2014 ·Expert Opinion on Emerging Drugs ·Ramya Kollipara, Christopher Downing, Michael H. Lee, Jacqueline Guidry, (unknown), Stephen K. Tyring	11
15	Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis 2011 ·Journal of the American Academy of Dermatology ·David M. Pariser, Craig L. Leonardi, Kenneth B. Gordon, Alice B. Gottlieb, Stephen K. Tyring, Kim Papp, Joanne Li, Scott W. Baumgartner	65
16	Mutations in the Regulatory Domain of Phenylalanine Hydroxylase and Response to Tetrahydrobiopterin 2007 ·Genetic Testing ·Lin Wang, Sankar Surendran, Kimberlee Michals‐Matalon, Gita Bhatia, (unknown), Richard Koch, James J. Grady, Stephen K. Tyring, Raymond C. Stevens, Flemming Güttler, Reuben Matalon	8
17	Inhibition ofSmoothenedSignaling Prevents Ultraviolet B-Induced Basal Cell Carcinomas through Regulation of Fas Expression and Apoptosis 2004 ·Cancer Research ·Mohammad Athar, Cheng‐Xin Li, Xiuwei Tang, Sumin Chi, Xiaoli Zhang, Arianna L. Kim, Stephen K. Tyring, Levy Kopelovich, Jennifer Hebert, Ervin H. Epstein, David R. Bickers, Jingwu Xie	140
18	The management of herpes simplex virus infections 2002 ·Current Opinion in Infectious Diseases ·(unknown), (unknown), (unknown), Stephen K. Tyring	14
19	Alteration in the Coding Potential and Expression of H-ras in Human Cytomegalovirus-Transformed Cells 1994 ·Intervirology ·István Boldogh, Eng‐Shang Huang, Peter L. Rady, István Arany, Stephen K. Tyring, Thomas Albrecht	14
20	p53 mutations in basal cell carcinomas. 1992 ·PubMed ·Peter L. Rady, Franco Scinicariello, Richard F. Wagner, Stephen K. Tyring	178

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact